Guardant Health shareholders reject advisory say-on-pay; director Krognes gets 28% withhold votes

Guardant Health, Inc.

Advisory vote on named executive officer compensation failed: 84.6M for, 5.8M against, 0.6M abstain.
Director nominee Steve Krognes received 64.4M for and 25.6M withheld (approx 28% withhold).
Other directors Eltoukhy and Talasaz elected with >98% votes for; auditor ratification approved.
Say-on-pay is non-binding but signals shareholder discontent; Krognes opposition notable.
Meeting held June 12, 2024; broker non-votes on director and say-on-pay were 6.2M shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.